Flanders M, Tischler A, Wise J, Williams F, Beneish R, Auger N
Can J Ophthalmol. 1987 Jun;22(4):212-7.
Between July 1984 and March 1985, 51 injections of type A botulinum toxin were given to 39 patients aged 11 to 81 years with various types of strabismus, including paralytic strabismus, sensory exotropia, consecutive and residual postsurgical deviations and partially accommodative esotropia. All deviations were documented by orthoptic assessment and photography. After treatment the patients were followed for up to 3 years. The beneficial effects of a single injection were modest, and a second injection was often necessary to achieve satisfactory ocular alignment. Thirteen of the 26 patients (50%) with nonparalytic strabismus and 10 of the 13 patients (77%) with paralytic strabismus had a good outcome (final deviation 12 prism dioptres or less). Adverse side effects included transient ptosis and diplopia and inadvertent vertical deviation. Twenty-one consecutive cases of nonparalytic horizontal strabismus treated with adjustable sutures were also reviewed. The results in these patients were more predictable and longer lasting than those in the patients who received botulinum toxin.
1984年7月至1985年3月期间,对39例年龄在11至81岁之间患有各种斜视的患者进行了51次A型肉毒杆菌毒素注射,这些斜视包括麻痹性斜视、感觉性外斜视、连续性和残留性术后斜视以及部分调节性内斜视。所有斜视情况均通过斜视检查评估和摄影记录。治疗后对患者进行了长达3年的随访。单次注射的有益效果不明显,通常需要第二次注射才能实现令人满意的眼位矫正。26例非麻痹性斜视患者中有13例(50%),13例麻痹性斜视患者中有10例(77%)取得了良好效果(最终斜视度为12棱镜度或更小)。不良反应包括短暂性上睑下垂、复视和意外的垂直斜视。还回顾了21例接受可调节缝线治疗的连续性非麻痹性水平斜视病例。这些患者的治疗结果比接受肉毒杆菌毒素治疗的患者更可预测且持续时间更长。